89bio Financials

Earnings View

Profitability View

Liquidity View

Fundamentals View

Competition View

89bio Stock Summary

89bio competes with Eliem Therapeutics, HCW Biologics, Scpharmaceuticals, Milestone Pharmaceuticals, and Seres Therapeutics. 89bio, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapies for the treatment of liver and cardio-metabolic diseases. The company also intends to develop pegozafermin for the treatment of severe hypertriglyceridemia. 89bio, Inc. was incorporated in 2018 and is headquartered in San Francisco, California. 89Bio operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 41 people.

89bio Key Financial Ratios

89bio Key Balance Sheet Accounts

89bio Key Income Statement Accounts

89bio Key Cash Accounts

89bio Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining 89bio's current stock value. Our valuation model uses many indicators to compare 89bio value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across 89bio competition to find correlations between indicators driving 89bio's intrinsic value. More Info.89bio Inc is rated # 2 in return on equity category among its peers. It is rated # 4 in return on asset category among its peers . At present, 89bio's Return On Equity is projected to slightly decrease based on the last few years of reporting. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the 89bio's earnings, one of the primary drivers of an investment's value.

89bio Inc Systematic Risk

Today, most investors in 89bio Stock are looking for potential investment opportunities by analyzing not only static indicators but also various 89bio's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of 89bio growth as a starting point in their analysis.

Along with financial statement analysis, the daily predictive indicators of 89bio help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of 89bio Inc. We use our internally-developed statistical techniques to arrive at the intrinsic value of 89bio Inc based on widely used predictive technical indicators. In general, we focus on analyzing 89bio Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build 89bio's daily price indicators and compare them against related drivers.

When running 89bio's price analysis, check to measure 89bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy 89bio is operating at the current time. Most of 89bio's value examination focuses on studying past and present price action to predict the probability of 89bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move 89bio's price. Additionally, you may evaluate how the addition of 89bio to your portfolios can decrease your overall portfolio volatility.